Chronic sleep disturbance and neural injury: links to neurodegenerative disease

References

• EspanaRAScammellTESleep neurobiology from a clinical perspectiveSleep201134784585821731134
   PubMed Web of Science ®Google Scholar
• VitielloMVBorsonSSleep disturbances in patients with Alzheimer’s disease: epidemiology, pathophysiology and treatmentCNS Drugs2001151077779611602004
   PubMed Web of Science ®Google Scholar
• AbbottSMZeePCIrregular sleep-wake rhythm disorderSleep Med Clin201510451752226568126
   PubMedGoogle Scholar
• TractenbergRESingerCMKayeJASymptoms of sleep disturbance in persons with Alzheimer’s disease and normal elderlyJ Sleep Res200514217718515910515
   PubMed Web of Science ®Google Scholar
• WisorJPEdgarDMYesavageJSleep and circadian abnormalities in a transgenic mouse model of Alzheimer’s disease: a role for cholinergic transmissionNeuroscience2005131237538515708480
   PubMed Web of Science ®Google Scholar
• OkawaMMishimaKHishikawaYHozumiSHoriHTakahashiKCircadian rhythm disorders in sleep-waking and body temperature in elderly patients with dementia and their treatmentSleep19911464784851798879
   PubMed Web of Science ®Google Scholar
• WittingWKwaIHEikelenboomPMirmiranMSwaabDFAlterations in the circadian rest-activity rhythm in aging and Alzheimer’s diseaseBiol Psychiatry19902765635722322616
   PubMed Web of Science ®Google Scholar
• LimASYuLCostaMDIncreased fragmentation of rest-activity patterns is associated with a characteristic pattern of cognitive impairment in older individualsSleep2012355633B640B22547889
   PubMed Web of Science ®Google Scholar
• TranahGJBlackwellTStoneKLCircadian activity rhythms and risk of incident dementia and mild cognitive impairment in older womenAnn Neurol201170572273222162057
   PubMed Web of Science ®Google Scholar
• ChiuHYLinEYWeiLHypnotics use but not insomnia increased the risk of dementia in traumatic brain injury patientsEur Neuropsychopharmacol Epub2015108
   Web of Science ®Google Scholar
• BohlkenJSchulzMRappMABatzing-FeigenbaumJPharmacotherapy of dementia in Germany: results from a nationwide claims databaseEur Neuropsychopharmacol Epub2015103
   Web of Science ®Google Scholar
• VidenovicAGolombekDCircadian and sleep disorders in Parkinson’s diseaseExp Neurol2013243455622935723
   PubMed Web of Science ®Google Scholar
• VidenovicALazarASBarkerRAOvereemS‘The clocks that time us’–circadian rhythms in neurodegenerative disordersNat Rev Neurol2014101268369325385339
   PubMed Web of Science ®Google Scholar
• RascolOBrooksDJKorczynADDe DeynPPClarkeCELangAEA five-year study of the incidence of dyskinesia in patients with early Parkinson’s disease who were treated with ropinirole or levodopa. 056 Study GroupN Engl J Med2000342201484149110816186
   PubMed Web of Science ®Google Scholar
• PSGPramipexole vs levodopa as initial treatment for Parkinson disease: a randomized controlled trialJAMA20002841931193811035889
   PubMed Web of Science ®Google Scholar
• PausSBrechtHMKosterJSeegerGKlockgetherTWullnerUSleep attacks, daytime sleepiness, and dopamine agonists in Parkinson’s diseaseMov Disord200318665966712784269
   PubMed Web of Science ®Google Scholar
• RyeDBSleepiness and unintended sleep in Parkinson’s diseaseCurr Treat Options Neurol20035323123912670412
   PubMedGoogle Scholar
• GoodmanAOMortonAJBarkerRAIdentifying sleep disturbances in Huntington’s disease using a simple disease-focused questionnairePLoS Curr20102RRN118920972477
   PubMedGoogle Scholar
• MortonAJCircadian and sleep disorder in Huntington’s diseaseExp Neurol2013243344423099415
   PubMed Web of Science ®Google Scholar
• MortonAJWoodNIHastingsMHHurelbrinkCBarkerRAMaywoodESDisintegration of the sleep-wake cycle and circadian timing in Huntington’s diseaseJ Neurosci200525115716315634777
   PubMed Web of Science ®Google Scholar
• PallierPNMaywoodESZhengZPharmacological imposition of sleep slows cognitive decline and reverses dysregulation of circadian gene expression in a transgenic mouse model of Huntington’s diseaseJ Neurosci200727297869787817634381
   PubMed Web of Science ®Google Scholar
• ZanigniSCalandra-BuonauraGGrimaldiDCortelliPREM behaviour disorder and neurodegenerative diseasesSleep Med201112Suppl 2S54S5822136901
   PubMed Web of Science ®Google Scholar
• PostumaRBGagnonJFVendetteMFantiniMLMassicotte-MarquezJMontplaisirJQuantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorderNeurology200972151296130019109537
   PubMed Web of Science ®Google Scholar
• LimASEllisonBAWangJLSleep is related to neuron numbers in the ventrolateral preoptic/intermediate nucleus in older adults with and without Alzheimer’s diseaseBrain2014137Pt 102847286125142380
   PubMed Web of Science ®Google Scholar
• WangJLLimASChiangWYSuprachiasmatic neuron numbers and rest-activity circadian rhythms in older humansAnn Neurol201578231732225921596
   PubMed Web of Science ®Google Scholar
• BraakHDel TrediciKInvited article: nervous system pathology in sporadic Parkinson diseaseNeurology200870201916192518474848
   PubMed Web of Science ®Google Scholar
• BraakHDel TrediciKRubUde VosRAJansen SteurENBraakEStaging of brain pathology related to sporadic Parkinson’s diseaseNeurobiol Aging200324219721112498954
   PubMed Web of Science ®Google Scholar
• BordetRDevosDBriqueSStudy of circadian melatonin secretion pattern at different stages of Parkinson’s diseaseClin Neuropharmacol2003262657212671525
   PubMed Web of Science ®Google Scholar
• VidenovicANobleCReidKJCircadian melatonin rhythm and excessive daytime sleepiness in Parkinson diseaseJAMA Neurol201471446346924566763
   PubMed Web of Science ®Google Scholar
• BreenDPVuonoRNawarathnaUSleep and circadian rhythm regulation in early Parkinson diseaseJAMA Neurol201471558959524687146
   PubMed Web of Science ®Google Scholar
• OhashiYOkamotoNUchidaKIyoMMoriNMoritaYDaily rhythm of serum melatonin levels and effect of light exposure in patients with dementia of the Alzheimer’s typeBiol Psychiatry199945121646165210376127
   PubMed Web of Science ®Google Scholar
• SkeneDJSwaabDFMelatonin rhythmicity: effect of age and Alzheimer’s diseaseExp Gerontol2003381–219920612543278
   PubMed Web of Science ®Google Scholar
• SaravananKSSindhuKMMohanakumarKPMelatonin protects against rotenone-induced oxidative stress in a hemiparkinsonian rat modelJ Pineal Res200742324725317349022
   PubMed Web of Science ®Google Scholar
• Acuna-CastroviejoDCoto-MontesAGaia MontiMOrtizGGReiterRJMelatonin is protective against MPTP-induced striatal and hippocampal lesionsLife Sci1997602PL23PL299000122
   PubMed Web of Science ®Google Scholar
• OnoKMochizukiHIkedaTEffect of melatonin on alpha-synuclein self-assembly and cytotoxicityNeurobiol Aging20123392172218522118903
   PubMed Web of Science ®Google Scholar
• HaganJJLeslieRAPatelSOrexin A activates locus coeruleus cell firing and increases arousal in the ratProc Natl Acad Sci U S A19999619109111091610485925
   PubMed Web of Science ®Google Scholar
• PeyronCFaracoJRogersWA mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brainsNat Med20006999199710973318
   PubMed Web of Science ®Google Scholar
• WilliamsRHMortonAJBurdakovDParadoxical function of orexin/hypocretin circuits in a mouse model of Huntington’s diseaseNeurobiol Dis201142343844521324360
   PubMed Web of Science ®Google Scholar
• PetersenAGilJMaat-SchiemanMLOrexin loss in Huntington’s diseaseHum Mol Genet2005141394715525658
   PubMed Web of Science ®Google Scholar
• van WamelenDJAzizNARoosRASwaabDFHypothalamic alterations in Huntington’s disease patients: comparison with genetic rodent modelsJ Neuroendocrinol2014261176177525074766
   PubMed Web of Science ®Google Scholar
• BjorkqvistMPetersenANielsenJCerebrospinal fluid levels of orexin-A are not a clinically useful biomarker for Huntington diseaseClin Genet2006701787916813610
   PubMed Web of Science ®Google Scholar
• BaumannCRHersbergerMBassettiCLHypocretin-1 (orexin A) levels are normal in Huntington’s diseaseJ Neurol200625391232123316598614
   PubMed Web of Science ®Google Scholar
• GausSELinLMignotECSF hypocretin levels are normal in Huntington’s disease patientsSleep200528121607160816408421
   PubMed Web of Science ®Google Scholar
• MeierAMollenhauerBCohrsSNormal hypocretin-1 (orexin-A) levels in the cerebrospinal fluid of patients with Huntington’s diseaseBrain Res20051063220120316263095
   PubMed Web of Science ®Google Scholar
• OvereemSvan HiltenJJRipleyBMignotENishinoSLammersGJNormal hypocretin-1 levels in Parkinson’s disease patients with excessive daytime sleepinessNeurology200258349849911839864
   PubMed Web of Science ®Google Scholar
• BaumannCFerini-StrambiLWaldvogelDWerthEBassettiCLParkinsonism with excessive daytime sleepiness – a narcolepsy-like disorder?J Neurol2005252213914515729517
   PubMed Web of Science ®Google Scholar
• YasuiKInoueYKanbayashiTNomuraTKusumiMNakashimaKCSF orexin levels of Parkinson’s disease, dementia with Lewy bodies, progressive supranuclear palsy and corticobasal degenerationJ Neurol Sci20062501–212012317005202
   PubMed Web of Science ®Google Scholar
• DrouotXMoutereauSNguyenJPLow levels of ventricular CSF orexin/hypocretin in advanced PDNeurology200361454054312939433
   PubMed Web of Science ®Google Scholar
• FronczekROvereemSLeeSYHypocretin (orexin) loss in Parkinson’s diseaseBrain2007130Pt 61577158517470494
   PubMed Web of Science ®Google Scholar
• FengYLiuTLiXQNeuroprotection by Orexin-A via HIF-1alpha induction in a cellular model of Parkinson’s diseaseNeurosci Lett2014579354025038418
   PubMed Web of Science ®Google Scholar
• RipleyBOvereemSFujikiNCSF hypocretin/orexin levels in narcolepsy and other neurological conditionsNeurology200157122253225811756606
   PubMed Web of Science ®Google Scholar
• FronczekRvan GeestSFrolichMHypocretin (orexin) loss in Alzheimer’s diseaseNeurobiol Aging20123381642165021546124
   PubMed Web of Science ®Google Scholar
• LiguoriCRomigiANuccetelliMOrexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer diseaseJAMA Neurol201471121498150525322206
   PubMed Web of Science ®Google Scholar
• RohJHJiangHFinnMBPotential role of orexin and sleep modulation in the pathogenesis of Alzheimer’s diseaseJ Exp Med2014211132487249625422493
   PubMed Web of Science ®Google Scholar
• KangJELimMMBatemanRJAmyloid-beta dynamics are regulated by orexin and the sleep-wake cycleScience200932659551005100719779148
   PubMed Web of Science ®Google Scholar
• NedergaardMNeuroscience. Garbage truck of the brainScience201334061401529153023812703
   PubMed Web of Science ®Google Scholar
• XieLKangHXuQSleep drives metabolite clearance from the adult brainScience2013342615637337724136970
   PubMed Web of Science ®Google Scholar
• Di MecoAJoshiYBPraticoDSleep deprivation impairs memory, tau metabolism, and synaptic integrity of a mouse model of Alzheimer’s disease with plaques and tanglesNeurobiol Aging20143581813182024629673
   PubMed Web of Science ®Google Scholar
• YoungTPaltaMDempseyJSkatrudJWeberSBadrSThe occurrence of sleep-disordered breathing among middle-aged adultsNew Engl J Med199332817123012358464434
   PubMed Web of Science ®Google Scholar
• BonnetMHArandDLClinical effects of sleep fragmentation versus sleep deprivationSleep Med Rev20037429731014505597
   PubMed Web of Science ®Google Scholar
• RothmanSMHerdenerNFrankolaKAMughalMRMattsonMPChronic mild sleep restriction accentuates contextual memory impairments, and accumulations of cortical Abeta and pTau in a mouse model of Alzheimer’s diseaseBrain Research2013152920020823856323
   PubMed Web of Science ®Google Scholar
• MaceyPMHendersonLAMaceyKEBrain morphology associated with obstructive sleep apneaAm J Respir Crit Care Med2002166101382138712421746
   PubMed Web of Science ®Google Scholar
• ZhangXLiLZhangXPrenatal hypoxia may aggravate the cognitive impairment and Alzheimer’s disease neuropathology in APPSwe/PS1A246E transgenic miceNeurobiol Aging201334366367822795785
   PubMed Web of Science ®Google Scholar
• QuanSFChanCSDementWCThe association between obstructive sleep apnea and neurocognitive performance – the Apnea Positive Pressure Long-term Efficacy Study (APPLES)Sleep2011343303B314B21358847
   PubMed Web of Science ®Google Scholar
• KushidaCANicholsDAHolmesTHEffects of continuous positive airway pressure on neurocognitive function in obstructive sleep apnea patients: the Apnea Positive Pressure Long-term Efficacy Study (APPLES)Sleep201235121593160223204602
   PubMed Web of Science ®Google Scholar
• ChenHSchernhammerESchwarzschildMAAscherioAA prospective study of night shift work, sleep duration, and risk of Parkinson’s diseaseAm J Epidemiol2006163872673016495472
   PubMed Web of Science ®Google Scholar
• HoglBPeraltaCWetterTCGershanikOTrenkwalderCEffect of sleep deprivation on motor performance in patients with Parkinson’s diseaseMov Disord200116461662111481684
   PubMed Web of Science ®Google Scholar
• ReistCSokolskiKNChenCCCoskinasEDemetEMThe effect of sleep deprivation on motor impairment and retinal adaptation in Parkinson’s diseaseProg Neuropsychopharmacol Biol Psychiatry19951934454547624495
   PubMed Web of Science ®Google Scholar
• van GilstMMvan MierloPBloemBROvereemSQuantitative motor performance and sleep benefit in Parkinson diseaseSleep201538101567157325902811
   PubMed Web of Science ®Google Scholar